ScienceDaily (July 26, 2008) — A multi-institutional team led by Massachusetts General Hospital (MGH) investigators has developed a powerful new tool for genomic research and medicine — a robust method for generating synthetic enzymes that can target particular DNA sequences for inactivation or repair.
more here
